Logo image
Differential effects of cytokines and corticosteroids on toll-like receptor 2 expression and activity in human airway epithelia
Journal article   Open access   Peer reviewed

Differential effects of cytokines and corticosteroids on toll-like receptor 2 expression and activity in human airway epithelia

Audra A Winder, Christine Wohlford-Lenane, Todd E Scheetz, Brie N Nardy, Lori J Manzel, Dwight C Look and Paul B McCray Jr
Respiratory research, Vol.10(1), pp.96-96
10/16/2009
DOI: 10.1186/1465-9921-10-96
PMCID: PMC2772856
PMID: 19835594
url
https://doi.org/10.1186/1465-9921-10-96View
Published (Version of record) Open Access

Abstract

The recognition of microbial molecular patterns via toll-like receptors (TLRs) is critical for mucosal defenses. Using well-differentiated primary cultures of human airway epithelia, we investigated the effects of exposure of the cells to cytokines (TNF-alpha and IFN-gamma) and dexamethasone (dex) on responsiveness to the TLR2/TLR1 ligand Pam3CSK4. Production of IL-8, CCL20, and airway surface liquid antimicrobial activity were used as endpoints. Microarray expression profiling in human airway epithelia revealed that first response cytokines markedly induced TLR2 expression. Real-time PCR confirmed that cytokines (TNF-alpha and IFN-gamma), dexamethasone (dex), or cytokines + dex increased TLR2 mRNA abundance. A synergistic increase was seen with cytokines + dex. To assess TLR2 function, epithelia pre-treated with cytokines +/- dex were exposed to the TLR2/TLR1 ligand Pam3CSK4 for 24 hours. While cells pre-treated with cytokines alone exhibited significantly enhanced IL-8 and CCL20 secretion following Pam3CSK4, mean IL-8 and CCL20 release decreased in Pam3CSK4 stimulated cells following cytokines + dex pre-treatment. This marked increase in inflammatory gene expression seen after treatment with cytokines followed by the TLR2 ligand did not correlate well with NF-kappaB, Stat1, or p38 MAP kinase pathway activation. Cytokines also enhanced TLR2 agonist-induced beta-defensin 2 mRNA expression and increased the antimicrobial activity of airway surface liquid. Dex blocked these effects. While dex treatment enhanced TLR2 expression, co-administration of dex with cytokines inhibited airway epithelial cell responsiveness to TLR2/TLR1 ligand over cytokines alone. Enhanced functional TLR2 expression following exposure to TNF-alpha and IFN-gamma may serve as a dynamic means to amplify epithelial innate immune responses during infectious or inflammatory pulmonary diseases.
Ligands Pseudomonas aeruginosa - immunology Tumor Necrosis Factor-alpha - metabolism Chemokine CCL20 - metabolism Respiratory Mucosa - drug effects Toll-Like Receptor 2 - genetics Oligonucleotide Array Sequence Analysis Lipopeptides - pharmacology Epithelial Cells - drug effects Humans Interferon-gamma - metabolism Listeria monocytogenes - immunology RNA, Messenger - metabolism Dexamethasone - pharmacology Interleukin-1beta - metabolism Respiratory Mucosa - immunology Inflammation Mediators - metabolism Toll-Like Receptor 2 - drug effects Interleukin-8 - metabolism Recombinant Proteins - metabolism Cytokines - metabolism Immunity, Innate - drug effects Cells, Cultured Adrenal Cortex Hormones - pharmacology Escherichia coli - immunology Gene Expression Profiling - methods Toll-Like Receptor 2 - metabolism Epithelial Cells - immunology

Details

Metrics

Logo image